Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. (5th August 2014)
- Record Type:
- Journal Article
- Title:
- Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. (5th August 2014)
- Main Title:
- Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
- Authors:
- Kyrtsonis, Marie-Christine
Sarris, Katerina
Koulieris, Efstathios
Maltezas, Dimitrios
Nikolaou, Eftychia
Angelopoulou, Maria K.
Bartzis, Vassiliki
Tzenou, Tatiana
Dimou, Maria
Siakandaris, Mariana P.
Viniou, Nora A.
Sachanas, Sotirios
Kalpadakis, Christina
Sfikakis, Petros P.
Pangalis, Gerassimos A.
Panayiotidis, Panayiotis - Other Names:
- Shimizu Kazuyuki Academic Editor.
- Abstract:
- Abstract : BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed from cells' surface and circulate in soluble form (sTACI). We investigated the impact of serum BLyS and sTACI levels at diagnosis in CLL patients and their relationship with disease parameters and patients' outcome. Serum BLyS was determined in 73 patients, while sTACI in 60. Frozen sera drawn at diagnosis were tested by ELISA. sTACI concentrations correlated with BLyS (P = - 0.000021 ), b2-microglobulin (P = 0.005 ), anemia (P = - 0.03 ), thrombocytopenia (P = 0.04 ), Binet stage (P = 0.02 ), and free light chains ratio (P = 0.0003 ). Soluble BLyS levels below median and sTACI values above median were related to shorter TFT (P = 0.0003 and 0.007). During a ten-year followup, sTACI levels, but not BLyS, correlated with survival (P = 0.048 ). In conclusion, we confirmed the prognostic significance of soluble BLyS levels with regard to TFT in CLL patients, and, more importantly, we showed for the first time that sTACI is a powerful prognostic marker, related to parameters of disease activity and staging and, more importantly, to TFT and OS.
- Is Part Of:
- BioMed research international. Volume 2014(2014)
- Journal:
- BioMed research international
- Issue:
- Volume 2014(2014)
- Issue Display:
- Volume 2014, Issue 2014 (2014)
- Year:
- 2014
- Volume:
- 2014
- Issue:
- 2014
- Issue Sort Value:
- 2014-2014-2014-0000
- Page Start:
- Page End:
- Publication Date:
- 2014-08-05
- Subjects:
- Medicine -- Periodicals
Biology -- Periodicals
Biotechnology -- Periodicals
Life sciences -- Periodicals
610.5 - Journal URLs:
- https://www.hindawi.com/journals/bmri/ ↗
- DOI:
- 10.1155/2014/159632 ↗
- Languages:
- English
- ISSNs:
- 2314-6133
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 23396.xml